These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3484854)
21. Seizures and action myoclonus after occupational exposure to methyl bromide. Prockop LD; Smith AO J Fla Med Assoc; 1986 Sep; 73(9):690-2. PubMed ID: 3772334 [No Abstract] [Full Text] [Related]
24. Serotonin models of myoclonus in the guinea pig and rat. Wolfson LI; Thal LJ; Brown LL Adv Neurol; 1986; 43():519-27. PubMed ID: 3484858 [TBL] [Abstract][Full Text] [Related]
28. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700 [TBL] [Abstract][Full Text] [Related]
29. What to do when Sinemet fails: Part one. Klawans HL Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692 [No Abstract] [Full Text] [Related]
30. Update on the treatment of Parkinson's disease. Wirz D Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903 [No Abstract] [Full Text] [Related]
31. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients]. García de Yébenes J; Mateo D; Pino MA; Cordero M; Pastor M; Chacón J; Morales B; Sánchez V; Mena MA; Giménez Roldán S Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023 [TBL] [Abstract][Full Text] [Related]
32. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
33. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa. Fermaglich J Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167 [No Abstract] [Full Text] [Related]
34. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease. Duggal HS; Singh I Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304 [No Abstract] [Full Text] [Related]
36. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J; Richardson JC; Rewcastle NB Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647 [TBL] [Abstract][Full Text] [Related]
38. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease]. Bermejo Pareja F; Martínez-Martín P Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135 [No Abstract] [Full Text] [Related]
39. Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Greene P; Cote L; Fahn S Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214 [No Abstract] [Full Text] [Related]
40. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Facca A; Sanchez-Ramos J Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]